Literature DB >> 15260442

Effects of different glucocorticoid treatments on serum acute phase proteins in dogs.

S Martínez-Subiela1, P J Ginel, J J Cerón.   

Abstract

The serum concentrations of haptoglobin, caeruloplasmin, C-reactive protein and serum amyloid A were measured in three groups of seven healthy dogs. Group 1 received a single dose of 1.1 mg/kg methylprednisolone acetate, administered subcutaneously; group 2 received 1 mg/kg per day of prednisone administered orally for three weeks; and group 3 received 2.2 mg/kg per day of prednisone administered orally for seven days. Before the administration of the glucocorticoids the serum concentrations of all the acute phase proteins were within the authors' laboratory reference ranges. After the administration of the drugs there were significant increases in the concentration of haptoglobin in all three groups, the increases being larger in groups 2 and 3. In contrast, the concentrations of C-reactive protein, caeruloplasmin and serum amyloid A were not affected.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15260442     DOI: 10.1136/vr.154.26.814

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  11 in total

1.  Effects of hemolysis, lipemia, hyperbilirrubinemia, and anticoagulants in canine C-reactive protein, serum amyloid A, and ceruloplasmin assays.

Authors:  Silvi Martínez-Subiela; Jose J Cerón
Journal:  Can Vet J       Date:  2005-07       Impact factor: 1.008

2.  Variation in inflammation as a correlate of range expansion in Kenyan house sparrows.

Authors:  Lynn B Martin; Jennifer L Alam; Titus Imboma; Andrea L Liebl
Journal:  Oecologia       Date:  2010-05-15       Impact factor: 3.225

3.  Validation of a commercially available human immunoturbidimetric assay for haptoglobin determination in canine serum samples.

Authors:  F Tecles; S Martínez Subiela; G Petrucci; C Gutiérrez Panizo; J J Cerón
Journal:  Vet Res Commun       Date:  2006-12-15       Impact factor: 2.459

4.  Serum insulin-like growth factor-1 measurements in dogs: performance characteristics of an automated assay and study of some sources of variation.

Authors:  Asta Tvarijonaviciute; Fernando Tecles; José M Carrillo; José M Carillo; Monica Rubio; José J Ceron
Journal:  Can J Vet Res       Date:  2011-10       Impact factor: 1.310

5.  Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs.

Authors:  Felicitas S Boretti; Paul W Buehler; Felice D'Agnillo; Katharina Kluge; Tony Glaus; Omer I Butt; Yiping Jia; Jeroen Goede; Claudia P Pereira; Marco Maggiorini; Gabriele Schoedon; Abdu I Alayash; Dominik J Schaer
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

6.  Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report.

Authors:  Mads Kjelgaard-Hansen; Asger Lundorff Jensen; Geoffrey A Houser; Lisbeth Rem Jessen; Annemarie T Kristensen
Journal:  Acta Vet Scand       Date:  2006-06-21       Impact factor: 1.695

7.  Modeling hemoglobin and hemoglobin:haptoglobin complex clearance in a non-rodent species-pharmacokinetic and therapeutic implications.

Authors:  Felicitas S Boretti; Jin Hyen Baek; Andre F Palmer; Dominik J Schaer; Paul W Buehler
Journal:  Front Physiol       Date:  2014-10-09       Impact factor: 4.566

8.  The Utility of Acute-Phase Proteins in the Assessment of Treatment Response in Dogs With Bacterial Pneumonia.

Authors:  S J Viitanen; A K Lappalainen; M B Christensen; S Sankari; M M Rajamäki
Journal:  J Vet Intern Med       Date:  2016-12-29       Impact factor: 3.333

9.  Early biomarkers of inflammation in dogs and cats: the acute phase proteins.

Authors:  S Paltrinieri
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

10.  Use of C-reactive protein concentration in evaluation of diskospondylitis in dogs.

Authors:  Sarah A Trub; William W Bush; Matthew Paek; Daniel E Cuff
Journal:  J Vet Intern Med       Date:  2020-12-14       Impact factor: 3.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.